OncoScint CR372 (Cytogen Corp)

N/A

Report date: 2024/01/10 15:13:56

Base Information

Drug NameOncoScint CR372 (Cytogen Corp)

Drug Alias NameC46

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo) > Contrast agent

Mechanisms of ActionSingle-photon emission-computed tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsContrast agents

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCytogen Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCytogen Corp

Active IndicationsN/A

Inactive IndicationsContrast agents

ATC CodeN/A